The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer

被引：95

作者：

Kapeleris, Joanna ^{[1
,2
]}

Kulasinghe, Arutha ^{[1
,2
]}

Warkiani, Majid E. ^{[3
,4
]}

Vela, Ian ^{[5
,6
]}

Kenny, Liz ^{[7
]}

O' Byrne, Kenneth ^{[1
,2
,8
]}

Punyadeera, Chamindie ^{[1
,2
]}

机构：

[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Kelvin Grove, Qld, Australia

[2] Translat Res Inst, Brisbane, Qld, Australia

[3] Univ Technol Sydney, Sch Biomed Engn, Sydney, NSW, Australia

[4] IM Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia

[5] Princess Alexandra Hosp, Dept Urol, Woolloongabba, Qld, Australia

[6] Queensland Univ Technol, Australian Prostate Canc Res Ctr, Inst Hlth & Biomed Innovat, Translat Res Inst,Princess Alexandra Hosp, Brisbane, Qld, Australia

[7] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Cent Integrated Reg Canc Serv,Queensland Hlth, Brisbane, Qld, Australia

[8] Princess Alexandra Hosp, Queensland Hlth, Brisbane, Qld, Australia

来源：

FRONTIERS IN ONCOLOGY | 2018年 / 8卷

关键词：

lung cancer; NSCLC; SCLC; Circulating tumor cells; liquid biopsy; PROGRESSION-FREE SURVIVAL; CLINICAL-SIGNIFICANCE; BREAST-CANCER; PERIPHERAL-BLOOD; MUTATIONAL ANALYSIS; MOLECULAR ANALYSIS; PROSTATE-CANCER; PULMONARY VEIN; CHEMOTHERAPY; EGFR;

D O I：

10.3389/fonc.2018.00311

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer affects over 1.8 million people worldwide and is the leading cause of cancer related mortality globally. Currently, diagnosis of lung cancer involves a combination of imaging and invasive biopsies to confirm histopathology. Non-invasive diagnostic techniques under investigation include "liquid biopsies" through a simple blood draw to develop predictive and prognostic biomarkers. A better understanding of circulating tumor cell (CTC) dissemination mechanisms offers promising potential for the development of techniques to assist in the diagnosis of lung cancer. Enumeration and characterization of CTCs has the potential to act as a prognostic biomarker and to identify novel drug targets for a precision medicine approach to lung cancer care. This review will focus on the current status of CTCs and their potential diagnostic and prognostic utility in this setting.

引用

页数：13

共 165 条

[51] Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
Harouaka, Ramdane
Kang, Zhigang
Zheng, Si-Yang
Cao, Liang
[J]. PHARMACOLOGY & THERAPEUTICS, 2014, 141 (02) : 209 - 221
[52] Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands
He, Wei
Kularatne, Surnith A.
Kalli, Kimberly R.
Prendergast, Franklyn G.
Amato, Robert J.
Klee, George G.
Hartmann, Lynn C.
Low, Philip S.
[J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (08) : 1968 - 1973
[53] Metastatic patterns in adenocarcinoma
Hess, KR
Varadhachary, GR
Taylor, SH
Wei, W
Raber, MN
Lenzi, R
Abbruzzese, JL
[J]. CANCER, 2006, 106 (07) : 1624 - 1633
[54] Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Hidalgo, Manuel
Amant, Frederic
Biankin, Andrew V.
Budinska, Eva
Byrne, Annette T.
Caldas, Carlos
Clarke, Robert B.
de Jong, Steven
Jonkers, Jos
Maelandsmo, Gunhild Mari
Roman-Roman, Sergio
Seoane, Joan
Trusolino, Livio
Villanueva, Alberto
[J]. CANCER DISCOVERY, 2014, 4 (09) : 998 - 1013
[55] In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods
Hillig, Thore
Horn, Peer
Nygaard, Ann-Britt
Haugaard, Anastasiya S.
Nejlund, Sarah
Brandslund, Ivan
Soletormos, Gyorgy
[J]. TUMOR BIOLOGY, 2015, 36 (06) : 4597 - 4601
[56] Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
Hiltermann, T. J. N.
Pore, M. M.
van den Berg, A.
Timens, W.
Boezen, H. M.
Liesker, J. J. W.
Schouwink, J. H.
Wijnands, W. J. A.
Kerner, G. S. M. A.
Kruyt, F. A. E.
Tissing, H.
Tibbe, A. G. J.
Terstappen, L. W. M. M.
Groen, H. J. M.
[J]. ANNALS OF ONCOLOGY, 2012, 23 (11) : 2937 - 2942
[57] Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer
Hirose, Takashi
Murata, Yasunori
Oki, Yasunari
Sugiyama, Tomohide
Kusumoto, Sojiro
Ishida, Hiroo
Shirai, Takao
Nakashima, Masano
Yamaoka, Toshimitsu
Okuda, Kentaro
Ohnishi, Tsukasa
Ohmori, Tohru
[J]. ONCOLOGY RESEARCH, 2012, 20 (2-3) : 131 - 137
[58] Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Hodgkinson, Cassandra L.
Morrow, Christopher J.
Li, Yaoyong
Metcalf, Robert L.
Rothwell, Dominic G.
Trapani, Francesca
Polanski, Radoslaw
Burt, Deborah J.
Simpson, Kathryn L.
Morris, Karen
Pepper, Stuart D.
Nonaka, Daisuke
Greystoke, Alastair
Kelly, Paul
Bola, Becky
Krebs, Matthew G.
Antonello, Jenny
Ayub, Mahmood
Faulkner, Suzanne
Priest, Lynsey
Carter, Louise
Tate, Catriona
Miller, Crispin J.
Blackhall, Fiona
Brady, Ged
Dive, Caroline
[J]. NATURE MEDICINE, 2014, 20 (08) : 897 - 903
[59] Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
Hofman, V.
Long, E.
Ilie, M.
Bonnetaud, C.
Vignaud, J. M.
Flejou, J. F.
Lantuejoul, S.
Piaton, E.
Mourad, N.
Butori, C.
Selva, E.
Marquette, C. H.
Poudenx, M.
Sibon, S.
Kelhef, S.
Venissac, N.
Jais, J. P.
Mouroux, J.
Molina, T. J.
Vielh, P.
Hofman, P.
[J]. CYTOPATHOLOGY, 2012, 23 (01) : 30 - 38
[60] Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Hofman, Veronique
Bonnetaud, Christelle
Ilie, Marius I.
Vielh, Philippe
Vignaud, Jean Michel
Flejou, Jean Francois
Lantuejoul, Sylvie
Piaton, Eric
Mourad, Nadine
Butori, Catherine
Selva, Eric
Poudenx, Michel
Sibon, Stephanie
Kelhef, Sabrina
Venissac, Nicolas
Jais, Jean-Philippe
Mouroux, Jerome
Molina, Thierry Jo
Hofman, Paul
[J]. CLINICAL CANCER RESEARCH, 2011, 17 (04) : 827 - 835

← 1 2 3 4 5 6 7 8 9 10 →